We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
+$1.27B
Cap. Flow
+$1.03B
Cap. Flow %
8.56%
Top 10 Hldgs %
10.66%
Holding
624
New
180
Increased
169
Reduced
84
Closed
163

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$135M
2
NXPI icon
NXP Semiconductors
NXPI
+$129M
3
FANG icon
Diamondback Energy
FANG
+$103M
4
TXN icon
Texas Instruments
TXN
+$98.4M
5
CRM icon
Salesforce
CRM
+$96.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$217M
2
PANW icon
Palo Alto Networks
PANW
+$120M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$120M
4
LNKD
LinkedIn Corporation
LNKD
+$110M
5
MRK icon
Merck
MRK
+$100M

Sector Composition

Rank Sector Weight
1 Technology 15.27%
2 Industrials 13.28%
3 Healthcare 12.87%
4 Consumer Discretionary 10.6%
5 Consumer Staples 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCC
376
WESCO International
WCC
$17.7B
$2.62M 0.02%
+39,373
New +$2.5M
INSM icon
377
Insmed
INSM
$28.6B
$2.54M 0.02%
+192,020
New +$2.62M
AGN
378
DELISTED
Allergan plc
AGN
$2.51M 0.02%
11,957
+8,724
+270% +$1.81M
GVA icon
379
Granite Construction
GVA
$5.62B
$2.45M 0.02%
44,592
-191,799
-81% -$10.2M
FENX
380
DELISTED
Fenix Parts, Inc.
FENX
$2.42M 0.02%
856,531
+6,129
+0.7% +$20.9K
TIG
381
DELISTED
TiGenix American Depositary Shares
TIG
$2.33M 0.02%
+160,000
New +$2.32M
ATYR
382
aTyr Pharma
ATYR
$50.1M
$2.31M 0.02%
76,579
+2,284
+3% +$93.7K
GNMK
383
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.2M 0.02%
179,523
-114,290
-39% -$1.36M
CFRX
384
CALL
DELISTED
ContraFect Corporation
CFRX
$2.19M 0.02%
1,563
– –
ATRS
385
DELISTED
Antares Pharma, Inc.
ATRS
$2.15M 0.02%
920,931
-118,859
-11% -$226K
XOP icon
386
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
$2.07M 0.02%
+12,500
New +$1.96M
VCEL icon
387
Vericel Corp
VCEL
$2.31B
$2.06M 0.02%
+687,725
New +$1.77M
CUBE icon
388
CubeSmart
CUBE
$9.41B
$1.96M 0.02%
+73,252
New +$1.88M
IRT icon
389
Independence Realty Trust
IRT
$4.07B
$1.89M 0.02%
211,811
-1,348,189
-86% -$11.7M
PACB icon
390
Pacific Biosciences
PACB
$370M
$1.88M 0.02%
+494,100
New +$3.59M
NTLA icon
391
Intellia Therapeutics
NTLA
$1.67B
$1.83M 0.02%
140,000
+105,000
+300% +$1.58M
ITT icon
392
ITT
ITT
$19.1B
$1.83M 0.02%
+47,400
New +$1.79M
BOLD
393
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.82M 0.02%
99,895
-21,840
-18% -$377K
WK icon
394
Workiva
WK
$3.54B
$1.81M 0.02%
132,380
-92,620
-41% -$1.42M
MNDT
395
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.78M 0.01%
+150,000
New +$1.95M
AIXC
396
AIxCrypto Holdings Inc
AIXC
$16.6M
$1.77M 0.01%
+5
New +$1.51M
ZWS icon
397
Zurn Elkay Water Solutions
ZWS
$8.53B
$1.76M 0.01%
+186,392
New +$1.8M
PTN
398
Palatin Technologies
PTN
$13.8M
$1.75M 0.01%
+2,773
New +$1.93M
CLNY
399
DELISTED
Colony Capital, Inc.
CLNY
$1.72M 0.01%
+84,727
New +$1.66M
ARCT icon
400
Arcturus Therapeutics
ARCT
$211M
$1.71M 0.01%
116,359
-34,938
-23% -$522K
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2016 Portfolio in Review

As of Q4 2016, Alyeska Investment Group held 624 positions worth $12.1B, up 12% from $10.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group deployed $1.03B of net new capital in Q4 2016, opening 180 new positions and adding to 169 existing holdings. Its largest new stake was Texas Instruments: 1,378,860 shares worth $101M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $120M trimmed.

  • Alyeska Investment Group's largest Q4 2016 buy was Texas Instruments: 1,378,860 shares worth $101M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q4 2016, an estimated $135M increase.
  • Alyeska Investment Group's biggest Q4 2016 reduction was Palo Alto Networks, cutting an estimated $120M.
  • Alyeska Investment Group fully exited Apple in Q4 2016, selling an estimated $217M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $12.1B portfolio in Q4 2016.
  • Alyeska Investment Group opened 180 new positions and closed 163 in Q4 2016.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $12.1B.

Based on Alyeska Investment Group's 13F filing for Q4 2016, filed 14 Feb 2017.